Leukocyte count and cardiometabolic risk among healthy participants with parental type 2 diabetes

The pathobiology of prediabetes in a biracial cohort study

Alexander A. Boucher, Chimaroke Edeoga, Sotonte Ebenibo, Jim Wan, Samuel Dagogo-Jack

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: White blood cell (WBC) count has been associated with cardiometabolic risk, but the data for African Americans are conflicting. We determined whether WBC count predicts subclinical inflammation and cardiometabolic risk in African Americans, despite their known lower WBC count, compared to Caucasians. Research design and methods: The study cohort consisted of 334 normoglycemic subjects (153 Caucasian, 181 African American) with parental type 2 diabetes (T2DM), mean (± SD) age 43.90 ± 10.25 y and BMI 30.1 ± 6.84 kg/m2. Each subject underwent clinical examination and a standard oral glucose tolerance test (OGTT) to document glycemic status. Blood specimens were obtained for determination of WBC counts, lipid profile and C-reactive protein (CRP) levels. Metabolic syndrome components were identified, using the NCEP cut-offs for waist circumference, blood pressure, HDL cholesterol and triglyceride levels. Results: Leukocyte counts were lower by ∼400/cm3 (P=.04) in African Americans than Caucasians, and were significantly correlated with waist circumference, HDL cholesterol, triglycerides and 2-h OGTT plasma glucose (P=.024-.0009), but not blood pressure in both races. Leukocyte counts significantly predicted the presence of three or more components of the metabolic syndrome similarly in African Americans ( P=.0076) and Caucasians (P=.0078), as did CRP levels. Leukocyte counts correlated significantly with CRP levels in African Americans (r=.30, P<.0001) and Caucasians (r=.29, P=.0003). Conclusions: Our data indicate that WBC count, despite being lower in African Americans than Caucasians, predicts low-grade inflammation and cardiometabolic risk with similar magnitude in normoglycemic African Americans and Caucasians with parental T2DM.

Original languageEnglish (US)
Pages (from-to)445-450
Number of pages6
JournalEthnicity and Disease
Volume22
Issue number4
StatePublished - Sep 1 2012

Fingerprint

Prediabetic State
Leukocyte Count
African Americans
Type 2 Diabetes Mellitus
Healthy Volunteers
Cohort Studies
C-Reactive Protein
Waist Circumference
Glucose Tolerance Test
HDL Cholesterol
Triglycerides
Blood Pressure
Inflammation
Research Design
Lipids
Glucose

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Medicine(all)

Cite this

Leukocyte count and cardiometabolic risk among healthy participants with parental type 2 diabetes : The pathobiology of prediabetes in a biracial cohort study. / Boucher, Alexander A.; Edeoga, Chimaroke; Ebenibo, Sotonte; Wan, Jim; Dagogo-Jack, Samuel.

In: Ethnicity and Disease, Vol. 22, No. 4, 01.09.2012, p. 445-450.

Research output: Contribution to journalArticle

@article{1b2dd8f760164822b413bf62439dbe7a,
title = "Leukocyte count and cardiometabolic risk among healthy participants with parental type 2 diabetes: The pathobiology of prediabetes in a biracial cohort study",
abstract = "Objective: White blood cell (WBC) count has been associated with cardiometabolic risk, but the data for African Americans are conflicting. We determined whether WBC count predicts subclinical inflammation and cardiometabolic risk in African Americans, despite their known lower WBC count, compared to Caucasians. Research design and methods: The study cohort consisted of 334 normoglycemic subjects (153 Caucasian, 181 African American) with parental type 2 diabetes (T2DM), mean (± SD) age 43.90 ± 10.25 y and BMI 30.1 ± 6.84 kg/m2. Each subject underwent clinical examination and a standard oral glucose tolerance test (OGTT) to document glycemic status. Blood specimens were obtained for determination of WBC counts, lipid profile and C-reactive protein (CRP) levels. Metabolic syndrome components were identified, using the NCEP cut-offs for waist circumference, blood pressure, HDL cholesterol and triglyceride levels. Results: Leukocyte counts were lower by ∼400/cm3 (P=.04) in African Americans than Caucasians, and were significantly correlated with waist circumference, HDL cholesterol, triglycerides and 2-h OGTT plasma glucose (P=.024-.0009), but not blood pressure in both races. Leukocyte counts significantly predicted the presence of three or more components of the metabolic syndrome similarly in African Americans ( P=.0076) and Caucasians (P=.0078), as did CRP levels. Leukocyte counts correlated significantly with CRP levels in African Americans (r=.30, P<.0001) and Caucasians (r=.29, P=.0003). Conclusions: Our data indicate that WBC count, despite being lower in African Americans than Caucasians, predicts low-grade inflammation and cardiometabolic risk with similar magnitude in normoglycemic African Americans and Caucasians with parental T2DM.",
author = "Boucher, {Alexander A.} and Chimaroke Edeoga and Sotonte Ebenibo and Jim Wan and Samuel Dagogo-Jack",
year = "2012",
month = "9",
day = "1",
language = "English (US)",
volume = "22",
pages = "445--450",
journal = "Ethnicity and Disease",
issn = "1049-510X",
publisher = "ISHIB",
number = "4",

}

TY - JOUR

T1 - Leukocyte count and cardiometabolic risk among healthy participants with parental type 2 diabetes

T2 - The pathobiology of prediabetes in a biracial cohort study

AU - Boucher, Alexander A.

AU - Edeoga, Chimaroke

AU - Ebenibo, Sotonte

AU - Wan, Jim

AU - Dagogo-Jack, Samuel

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Objective: White blood cell (WBC) count has been associated with cardiometabolic risk, but the data for African Americans are conflicting. We determined whether WBC count predicts subclinical inflammation and cardiometabolic risk in African Americans, despite their known lower WBC count, compared to Caucasians. Research design and methods: The study cohort consisted of 334 normoglycemic subjects (153 Caucasian, 181 African American) with parental type 2 diabetes (T2DM), mean (± SD) age 43.90 ± 10.25 y and BMI 30.1 ± 6.84 kg/m2. Each subject underwent clinical examination and a standard oral glucose tolerance test (OGTT) to document glycemic status. Blood specimens were obtained for determination of WBC counts, lipid profile and C-reactive protein (CRP) levels. Metabolic syndrome components were identified, using the NCEP cut-offs for waist circumference, blood pressure, HDL cholesterol and triglyceride levels. Results: Leukocyte counts were lower by ∼400/cm3 (P=.04) in African Americans than Caucasians, and were significantly correlated with waist circumference, HDL cholesterol, triglycerides and 2-h OGTT plasma glucose (P=.024-.0009), but not blood pressure in both races. Leukocyte counts significantly predicted the presence of three or more components of the metabolic syndrome similarly in African Americans ( P=.0076) and Caucasians (P=.0078), as did CRP levels. Leukocyte counts correlated significantly with CRP levels in African Americans (r=.30, P<.0001) and Caucasians (r=.29, P=.0003). Conclusions: Our data indicate that WBC count, despite being lower in African Americans than Caucasians, predicts low-grade inflammation and cardiometabolic risk with similar magnitude in normoglycemic African Americans and Caucasians with parental T2DM.

AB - Objective: White blood cell (WBC) count has been associated with cardiometabolic risk, but the data for African Americans are conflicting. We determined whether WBC count predicts subclinical inflammation and cardiometabolic risk in African Americans, despite their known lower WBC count, compared to Caucasians. Research design and methods: The study cohort consisted of 334 normoglycemic subjects (153 Caucasian, 181 African American) with parental type 2 diabetes (T2DM), mean (± SD) age 43.90 ± 10.25 y and BMI 30.1 ± 6.84 kg/m2. Each subject underwent clinical examination and a standard oral glucose tolerance test (OGTT) to document glycemic status. Blood specimens were obtained for determination of WBC counts, lipid profile and C-reactive protein (CRP) levels. Metabolic syndrome components were identified, using the NCEP cut-offs for waist circumference, blood pressure, HDL cholesterol and triglyceride levels. Results: Leukocyte counts were lower by ∼400/cm3 (P=.04) in African Americans than Caucasians, and were significantly correlated with waist circumference, HDL cholesterol, triglycerides and 2-h OGTT plasma glucose (P=.024-.0009), but not blood pressure in both races. Leukocyte counts significantly predicted the presence of three or more components of the metabolic syndrome similarly in African Americans ( P=.0076) and Caucasians (P=.0078), as did CRP levels. Leukocyte counts correlated significantly with CRP levels in African Americans (r=.30, P<.0001) and Caucasians (r=.29, P=.0003). Conclusions: Our data indicate that WBC count, despite being lower in African Americans than Caucasians, predicts low-grade inflammation and cardiometabolic risk with similar magnitude in normoglycemic African Americans and Caucasians with parental T2DM.

UR - http://www.scopus.com/inward/record.url?scp=84869070913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869070913&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 445

EP - 450

JO - Ethnicity and Disease

JF - Ethnicity and Disease

SN - 1049-510X

IS - 4

ER -